Dr. Malavaud, MD, PhD, FEBU, is Professor of Urology at Toulouse University (est. 1229) and Head of Onco-Urology at the Toulouse Cancer Institute, an OECI-accredited Comprehensive Cancer Center.
Beyond his clinical focus on prostate cancer (imaging, transperineal biopsy) and bladder cancer (en bloc endoscopic dissection), as well as on the positioning of medical innovation in oncology (meta-analyses, cost-of-care studies), his translational research has centered on sphingolipid metabolism and the role of adipocytes in cancer.
He was awarded the 2004 European Association of Urology Crystal Matula Award in recognition of his contributions to science and urology. In 2016, he patented a technology enabling the capture of circulating tumor cells based on their physical characteristics (size and rigidity), and co-founded SmartCatch°, a spinoff of the French Council of Scientific Research.
He currently serves on the Board of the European Association of Urology, where he is in charge of membership.
Selected publications from PubMed
ProBIOPSY: A Multidisciplinary International Consensus on Standards for Prostate Biopsy.
Chernysheva D, Di Bello F, Avesani G, Baboudjian M, Barret E, Breda A, Briganti A, Budäus L, Comperat E, Diamand R, De Meerleer G, De Rooij M, Giganti F, Giannarini G, Goffin K, Hernández Mancera J, Jereczek-Fossa BA, Kasivisvanathan V, Kesch C, Klotz L, Lughezzani G, Malavaud B, Moore C, Murphy D, Oprea-Lager D, Padhani A, Panebianco V, Ploussard G, Rannikko A, Raspollini MR, Rembak-Szynkiewicz J, Schoots I, Spohn SK, Stabile A, Tilki D, Tree A, Walz J, MacLennan S, Sanguedolce F, EAU Section of Urological Imaging
Eur Urol. 2026 Sep;90(3):212-224 doi: 10.1016/j.eururo.2026.06.012.
A High Density of Impaired Tertiary Lymphoid Structures Is Associated with Higher Tumor Stage and Recurrence in Non-Muscle-Invasive Bladder Cancer.
Péricart S, Tosolini M, Roumiguie M, Saint A, Largeaud L, Gravelle P, Van Acker N, Brousset P, Malavaud B, Laurent C
Cancer Immunol Res. 2026 Aug 31 doi: 10.1158/2326-6066.CIR-26-0104.
Addition of a surgery-specific module to a perioperative, telemedicine program for improving functional outcomes after radical prostatectomy: a prospective, multicenter, non-randomized study.
Uleri A, Potiron E, Miaadi N, Pasticier G, Martini A, Deffar N, Vuong NS, Gourtaud G, Pradère B, Mroueh L, Malavaud B, Baboudjian M, Beauval JB, Rouffilange J, Brureau L, Ploussard G, Dariane C, de la Taille A
Prostate Cancer Prostatic Dis. 2026 Jun;29(2):373-377 doi: 10.1038/s41391-025-01026-y.
Extracellular matrix remodeling as a unique mechanism of expansion of periprostatic adipose tissue: implication for prostate cancer aggressiveness.
Estève D, Toulet A, Roumiguié M, Bu D, Lacombe M, Péricart S, Belles C, Manceau C, Houël C, Ducoux-Petit M, Van Acker N, Dauvillier S, Jia Y, Hernandez M, Moutahir M, Franchet C, Doumerc N, Thoulouzan M, Le Gonidec S, Valet P, Malavaud B, Burlet-Schiltz O, Bouloumié A, Scherer PE, Milhas D, Muller C
J Pathol. 2026 May;269(1):55-70 doi: 10.1002/path.70033.
Transition to a digital perioperative pathway for robot-assisted radical prostatectomy: impact on patient outcomes and adherence.
Buhas BA, Uleri A, Katzendorn O, Salin A, Lesourd M, Almeras C, Loison G, Tollon C, Pradère B, Beauval JB, Malavaud B, Ploussard G
BJU Int. 2026 Mar;137(3):473-479 doi: 10.1111/bju.70102.
Help your network discover Dr. Bernard Malavaud's clinical expertise.
